185 related articles for article (PubMed ID: 33072085)
1. Small Molecule NF-κB Inhibitors as Immune Potentiators for Enhancement of Vaccine Adjuvants.
Moser BA; Escalante-Buendia Y; Steinhardt RC; Rosenberger MG; Cassaidy BJ; Naorem N; Chon AC; Nguyen MH; Tran NT; Esser-Kahn AP
Front Immunol; 2020; 11():511513. PubMed ID: 33072085
[TBL] [Abstract][Full Text] [Related]
2. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
3. Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway.
Ahn KS; Sethi G; Shishodia S; Sung B; Arbiser JL; Aggarwal BB
Mol Cancer Res; 2006 Sep; 4(9):621-33. PubMed ID: 16966432
[TBL] [Abstract][Full Text] [Related]
4. Honokiol stimulates osteoblastogenesis by suppressing NF-κB activation.
Yamaguchi M; Arbiser JL; Weitzmann MN
Int J Mol Med; 2011 Dec; 28(6):1049-53. PubMed ID: 21887456
[TBL] [Abstract][Full Text] [Related]
5. Magnolol inhibits Streptococcus suis-induced inflammation and ROS formation via TLR2/MAPK/NF-κB signaling in RAW264.7 cells.
Zhang L; Wang J; Xu W; Sun Y; You J; Lu H; Song Y; Wei J; Li L
Pol J Vet Sci; 2018 Mar; 21(1):111-118. PubMed ID: 29624001
[TBL] [Abstract][Full Text] [Related]
6. Honokiol inhibits the inflammatory reaction during cerebral ischemia reperfusion by suppressing NF-κB activation and cytokine production of glial cells.
Zhang P; Liu X; Zhu Y; Chen S; Zhou D; Wang Y
Neurosci Lett; 2013 Feb; 534():123-7. PubMed ID: 23262090
[TBL] [Abstract][Full Text] [Related]
7. Honokiol suppresses TNF-α-induced migration and matrix metalloproteinase expression by blocking NF-κB activation via the ERK signaling pathway in rat aortic smooth muscle cells.
Zhu X; Wang Z; Hu C; Li Z; Hu J
Acta Histochem; 2014 May; 116(4):588-95. PubMed ID: 24360976
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory effects of magnolol and honokiol are mediated through inhibition of the downstream pathway of MEKK-1 in NF-kappaB activation signaling.
Lee J; Jung E; Park J; Jung K; Lee S; Hong S; Park J; Park E; Kim J; Park S; Park D
Planta Med; 2005 Apr; 71(4):338-43. PubMed ID: 15856410
[TBL] [Abstract][Full Text] [Related]
9. Anti-psoriatic effects of Honokiol through the inhibition of NF-κB and VEGFR-2 in animal model of K14-VEGF transgenic mouse.
Wen J; Wang X; Pei H; Xie C; Qiu N; Li S; Wang W; Cheng X; Chen L
J Pharmacol Sci; 2015 Jul; 128(3):116-24. PubMed ID: 26220468
[TBL] [Abstract][Full Text] [Related]
10. Honokiol suppresses TNF-α-induced neutrophil adhesion on cerebral endothelial cells by disrupting polyubiquitination and degradation of IκBα.
Chen PJ; Wang YL; Kuo LM; Lin CF; Chen CY; Tsai YF; Shen JJ; Hwang TL
Sci Rep; 2016 May; 6():26554. PubMed ID: 27212040
[TBL] [Abstract][Full Text] [Related]
11. Activation of NF-kappaB by the intracellular expression of NF-kappaB-inducing kinase acts as a powerful vaccine adjuvant.
Andreakos E; Williams RO; Wales J; Foxwell BM; Feldmann M
Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14459-64. PubMed ID: 16971487
[TBL] [Abstract][Full Text] [Related]
12. Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities.
Kumar A; Kumar Singh U; Chaudhary A
Future Med Chem; 2013 May; 5(7):809-29. PubMed ID: 23651094
[TBL] [Abstract][Full Text] [Related]
13. Communicating the role and value of vaccine adjuvants.
Gellin BG; Salisbury DM
Vaccine; 2015 Jun; 33 Suppl 2():B44-6. PubMed ID: 26022567
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory effect of 4-O-methylhonokiol, compound isolated from Magnolia officinalis through inhibition of NF-kappaB [corrected].
Oh JH; Kang LL; Ban JO; Kim YH; Kim KH; Han SB; Hong JT
Chem Biol Interact; 2009 Aug; 180(3):506-14. PubMed ID: 19539808
[TBL] [Abstract][Full Text] [Related]
15. Immunostimulatory effect of chitosan and quaternary chitosan: A review of potential vaccine adjuvants.
Li X; Xing R; Xu C; Liu S; Qin Y; Li K; Yu H; Li P
Carbohydr Polym; 2021 Jul; 264():118050. PubMed ID: 33910752
[TBL] [Abstract][Full Text] [Related]
16. Combination adjuvants: the next generation of adjuvants?
Mutwiri G; Gerdts V; van Drunen Littel-van den Hurk S; Auray G; Eng N; Garlapati S; Babiuk LA; Potter A
Expert Rev Vaccines; 2011 Jan; 10(1):95-107. PubMed ID: 21162624
[TBL] [Abstract][Full Text] [Related]
17. A NF-κB-Based High-Throughput Screening for Immune Adjuvants and Inhibitors.
Yu B; Li B; Chen T; Yang J; Wang X; Peng B; Hu Q
Inflammation; 2023 Apr; 46(2):598-611. PubMed ID: 36306023
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, Characterization and Biological Evaluation of Magnolol and Honokiol Derivatives with 1,3,5-Triazine of Metformin Cyclization.
Ren C; Wang J; Tan Y; Guo M; Guo J; Liu Y; Wu X; Feng Y
Molecules; 2020 Dec; 25(24):. PubMed ID: 33302335
[TBL] [Abstract][Full Text] [Related]
19. Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery.
Gregg KA; Harberts E; Gardner FM; Pelletier MR; Cayatte C; Yu L; McCarthy MP; Marshall JD; Ernst RK
mBio; 2017 May; 8(3):. PubMed ID: 28487429
[TBL] [Abstract][Full Text] [Related]
20. Formulation, high throughput in vitro screening and in vivo functional characterization of nanoemulsion-based intranasal vaccine adjuvants.
Wong PT; Leroueil PR; Smith DM; Ciotti S; Bielinska AU; Janczak KW; Mullen CH; Groom JV; Taylor EM; Passmore C; Makidon PE; O'Konek JJ; Myc A; Hamouda T; Baker JR
PLoS One; 2015; 10(5):e0126120. PubMed ID: 25962136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
